1. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
   Cory D. Bovenzi et al, 2015, BioMed Research International CrossRef
2. Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique
   TIAN TANG et al, 2015 CrossRef
3. CD147-induced cell proliferation is associated with Smad4 signal inhibition
   Hui Qin et al, 2017, Experimental Cell Research CrossRef
4. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
   Xiaoyan Xin et al, 2016, Sci Rep CrossRef
5. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
   Cheng Wang et al, 2019, BMC Cancer CrossRef
6. Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach
   Cecilia Granéli et al, 2014, Stem Cell Research CrossRef
7. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma
   Naohisa Futamura et al, 2014, Tumor Biol. CrossRef
8. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
   Anne Caudron et al, 2016, Exp Dermatol CrossRef
9. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin
   Jahnabi Roy et al, 2017, PLoS ONE CrossRef
10. Pulmonary Neuroendocrine Neoplasms
    Anna Rita Larici et al, 2020 CrossRef
11. Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer
    Xiaojun Zhang et al, 2017, Oncotarget CrossRef
12. Molecular Mechanisms of Canine Osteosarcoma Metastasis
    Sylwia S. Wilk et al, 2021, IJMS CrossRef
13. Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
    Xianliang Yang et al, 2021, Oncol Lett CrossRef
14. The content of sEMMPRIN/CD147 in the blood serum of patients with bone tumors and its relationship with the clinical and morphological characteristics of the disease
    N. E. Kushlinskii et al, 2023, Usp. mol. onkol CrossRef